The listed-company investor lens — what drives shareholder value: Indian Embedded Value, the appraisal (IEV → market-cap) bridge, capital & solvency strength, quality of earnings & governance readiness.
The appraisal bridge is textbook life-insurance value: IEV ₹80.79k Cr + ₹105.34k Cr of structural / future-new-business value = a ₹186.13k Cr market cap (~2.3× embedded value). Reported PAT is optically flat (+2%) on one-off GST-ITC & labour drag — underlying ~₹3.12k Cr grew ~29%. Make the PAT bridge audit-proof and clear the 13M/49M persistency up; 61M COVID-cohort watch block before the investor pack goes out.
3 of 4 headline metrics improving vs prior · still off target: Value of New Business (VNB) ₹6,670 Cr vs ₹7,600 Cr, Net Cash / Free Surplus ₹2,350 Cr vs ₹3,000 Cr, 13-Month Persistency 87.9% vs 90.0%
The lowest-% investor-readiness item is the top execution risk: 61M dip 58.1% — targeted renewal & win-back under way.
Targeted renewal & win-back on 2020-21 cohorts; monitor structural read-through.
61M persistency 58.1% (−550 bps) — COVID-era (2020-21) cohorts lapsing at 5 years; management flags non-structural.
The market looks through the one-off GST-ITC & labour-code drag: reported ₹2.47k Cr → underlying ₹3.12k Cr → run-rate ₹3.20k Cr. That normalization underpins the ~2.3× embedded-value re-rating.
Surface the normalized walk in investor comms; same GST-ITC drag on VNB margin.
Reported PAT ₹2,470 Cr (+2%); underlying ~₹3,120 Cr (+29%) ex GST-ITC reversal & labour-code.
The cockpit is strong day-to-day — but this is the investor lens. It cuts through to what drives a re-rating: embedded value & solvency, normalized earnings, the IEV → market-cap bridge and shareholder value, plus the governance items that build investor confidence. IEV ₹80.79k Cr + ₹105.34k Cr of structural value frame a ₹186.13k Cr market cap (~2.3× embedded value).
Reported PAT → add back one-off GST-ITC reversal & labour-code → Underlying PAT → run-rate persistency & mix uplift → prudent surrender-norm haircut → Run-rate normalized PAT.
So what: the market looks through the one-off GST-ITC & labour drag — reported ₹2.47k Cr is optically flat (+2%), but underlying ₹3.12k Cr grew ~29% and run-rate normalized ₹3.20k Cr is what a re-rating capitalizes, which is exactly why the PAT bridge has to be defensible to analysts.
Indian Embedded Value → + value of future new business → + franchise & distribution premium → Market capitalisation (~2.3× IEV).
Shareholder value: a life insurer is valued on embedded value, not an earnings multiple. IEV ₹80.79k Cr is the actuarial book of in-force value; the market adds ₹105.34k Cr of structural / future-new-business value to a ₹186.13k Cr market cap — ~2.3× embedded value. Sole promoter State Bank of India holds 55.32%.
Quarterly capital generation keeps the solvency ratio well above the IRDAI 1.50× floor; free surplus funds dividends & growth. SBI Life is debt-free.
| Period | Beg ASM | Capital gen | End ASM | RSM | Solvency | Kind |
|---|---|---|---|---|---|---|
| Q1 FY26 (act) | ₹18.30k Cr | +₹250 Cr | ₹18.55k Cr | ₹9.46k Cr | 1.96× | Actual |
| Q2 FY26 (act) | ₹18.55k Cr | +₹260 Cr | ₹18.81k Cr | ₹9.70k Cr | 1.94× | Actual |
| Q3 FY26 (act) | ₹18.81k Cr | +₹250 Cr | ₹19.06k Cr | ₹9.93k Cr | 1.92× | Actual |
| Q4 FY26 (act) | ₹19.06k Cr | +₹240 Cr | ₹19.30k Cr | ₹10.16k Cr | 1.90× | Actual |
| Q1 FY27 (fcst) | ₹19.30k Cr | +₹280 Cr | ₹19.58k Cr | ₹10.20k Cr | 1.92× | Forecast |
| Q2 FY27 (fcst) | ₹19.58k Cr | +₹300 Cr | ₹19.88k Cr | ₹10.25k Cr | 1.94× | Forecast |
SBI Life carries no external borrowings; growth is funded from solvency capital & free surplus — only office-lease liabilities appear on the balance sheet.
| Line | Kind | Balance | Rate | Maturity | Note |
|---|---|---|---|---|---|
| Lease liabilities (offices) | Lease | ₹120 Cr | ≈8.0% (IND-AS 116) | rolling | Office-lease liabilities on 1,230 own offices — the only balance-sheet 'debt'. |
| Borrowings / term debt | Term | ₹0 Cr | — | — | No external borrowings — SBI Life is debt-free. |
| Subordinated / hybrid capital | Sub-debt | ₹0 Cr | — | — | No sub-debt issued; capital is all shareholder equity + surplus. |
| Net debt | Net | ₹0 Cr | — | — | Net debt nil; free-surplus generative with a 190% solvency buffer. |
Persistency dips in the early years, then recovers as the book matures.
| Product cohort | Since | Persistency at launch | Yr 1 (dip) | Persistency now | Yr-1 lapse | Note |
|---|---|---|---|---|---|---|
| Smart Bonus (Par) | 2010 | 91% | 88% | 90% | 7% | Participating — highest persistency; bonus lock-in. |
| Retire Smart (Annuity) | 2015 | 92% | 88% | 90% | 6% | Annuity — very sticky, long-dated liabilities. |
| Smart Wealth Plus (ULIP) | 2016 | 88% | 82% | 86% | 12% | Unit-linked — market-sensitive lapse; largest in-force book. |
| Smart Platina (Non-Par) | 2018 | 89% | 84% | 88% | 10% | Non-par savings — sticky; surrender-norm change watched. |
| eShield Next (Protection) | 2019 | 84% | 79% | 82% | 16% | Protection — higher early lapse; margin-rich, small premium. |
| Smart Elite (ULIP) | 2020 | 87% | 80% | 84% | 13% | Premium / online ULIP; younger cohort, improving. |
Scale-up dips persistency early, then maturing cohorts recover toward 88–90% — except Protection (eShield Next), where margin-rich, small-premium term carries higher early lapse — the one soft spot investors will probe in the revenue-quality pack.
The top execution risk is the lowest-% item — 13M/49M persistency up; 61M COVID-cohort watch (74%): 61M dip 58.1% — targeted renewal & win-back under way.